Font Size: a A A
Keyword [Newly diagnosed multiple myeloma]
Result: 21 - 40 | Page: 2 of 4
21. Efficacy And Safety Of Lenalidomide For Treating The Newly Diagnosed Multiple Myeloma:A Meta-analysis
22. Prognostic Significance Of ?-H2AX Expression In Newly Diagnosed Multiple Myeloma Patients
23. Clinical Analysis Of Newly Diagnosed Multiple Myeloma Patients Complicated With Renal Insufficiency
24. The Efficacy And Safety Of Lenalidomide In The Maintenance Treatment Of Newly Diagnosed Multiple Myeloma Meta Analysis
25. Clinical Significance Of Peripheral Blood T Lymphocyte Subsets And Circulation Plasma Cells In Patients With Newly Diagnosed Multiple Myeloma
26. Predisposing Factor And Clinical Feature Of Pulmonary Infection In Patients With Newly Diagnosed Multiple Myeloma
27. The Cost-effectiveness Analysis Of Two Therapeutic Regimens In Patients With Newly Diagnosed Multiple Myeloma
28. The Relevance Between18F-FDG PET/CT Scans And Laboratory Data And The Prognostic Value Of 18F-FDG PET/CT In Patients With Newly Diagnosed Multiple Myeloma
29. Efficacy And Safety Of Domestic Bortezomib And Brand Name Bortezomib In The Treatment Of Newly Diagnosed Multiple Myeloma
30. The Clinical Study Of Bortezomib-based Regimen In The Treatment Of Newly Diagnosed Multiple Myeloma
31. Analysis Of Clinical Data Of 165 Newly Diagnosed Multiple Myeloma
32. Dynamic Monitoring Of Minimal Residual Disease Status To Evaluate Its Prognostic Significance In Newly Diagnosed Multiple Myeloma
33. The Study Of Yishenhuoxueyin And Low-dose Bortezomib Based Regimens In The Treatment Of Newly Diagnosised Multiple Myeloma In Elderly Patients
34. The Clinical Analysis Of 61 Cases Of Newly Diagnosed Multiple Myeloma In Patients Aged 45 Years And Younger
35. Establishment Of Prognostic Model Of Newly Diagnosed Multiple Myeloma
36. Clinical Characteristics And Predisposing Factors Of Pulmonary Infection In Patients With Newly Diagnosed Multiple Myeloma Treated With Bortezomib
37. The Value Of Peripheral Blood Mononuclear Cell/lymphocyte Ratio In The Prognosis Of Newly Diagnosed Multiple Myeloma Patients Treated With Bortezomib
38. Prognostic Value Of Immune Status Changes After Chemotherapy In Patients With Newly Diagnosed Multiple Myeloma
39. The Influence Of Cytogenetic Abnormalities,clinical Features And Chemotherapy Regimens On The Prognosis Of Newly Diagnosed Multiple Myeloma
40. Clinical Study Of Cinobufotalin Tablets Combined With TD Regimen In The Treatment Of Newly Diagnosed Multiple Myeloma With Syndrome Of Blockade Of Phlegm And Blood Stasis
  <<First  <Prev  Next>  Last>>  Jump to